DYSIS Medical

About:

DYSIS Medical is focused on developing imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.

Website: http://www.dysismedical.com

Twitter/X: DySISMedical

Top Investors: Albion Capital Group, Lundbeckfonden Ventures, Scottish Investment Bank, NBGI Ventures

Description:

DYSIS Medical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical has developed a proprietary technology that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.

Total Funding Amount:

25.5M GBP

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Livingston, West Lothian, United Kingdom

Founded Date:

2002-01-01

Contact Email:

info(AT)dysismedical.com

Founders:

Konstantinos Balas

Number of Employees:

11-50

Last Funding Date:

2018-07-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai